Literature DB >> 13446819

Experience in the treatment of hypertension with pentapyrrolidinium (ansolysen) in a hypertension outpatient clinic.

H Z POMERANTZ, S BARSKY, L GORDON, J WENER.   

Abstract

Entities:  

Keywords:  HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use

Mesh：

Substances：

Year:  1957        PMID： 13446819      PMCID： PMC1823968     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients.

Authors:  E D FREIS; E A PARTENOPE; L S LILIENFIELD; J C ROSE
Journal:  Circulation       Date:  1954-04       Impact factor: 29.690

2.  Action of a new methonium compound in arterial hypertension; pentamethylene 1 : 5-bis-n-(n-methyl-pyrrolidinium) bitartrate (M. & B. 2050A).

Authors:  F H SMIRK
Journal:  Lancet       Date:  1953-03-07       Impact factor: 79.321
  2 in total
  1 in total

1.  Office management of the hypertensive patient.

Authors:  E M HELLER
Journal:  Can Med Assoc J       Date:  1958-09-01       Impact factor: 8.262
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.